Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection
- 30 April 1999
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 117 (4) , 714-718
- https://doi.org/10.1016/s0022-5223(99)70291-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Clinical trial of tacrolimus versus cyclosporine in lung transplantationThe Annals of Thoracic Surgery, 1995
- Obliterative bronchiolitis after lung and heart-lung transplantationThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Bronchiolitis Obliterans in Recipients of Single, Double, and Heart-Lung TransplantationChest, 1995
- SYNERGISTIC INTERACTIONS OF CYCLOSPORINE AND RAPAMYCIN TO INHIBIT IMMUNE PERFORMANCES OF NORMAL HUMAN PERIPHERAL BLOOD LYMPHOCYTES IN VITROTransplantation, 1991
- RAPAMYCIN, A POTENT IMMUNOSUPPRESSIVE DRUG FOR VASCULARIZED HEART, KIDNEY, AND SMALL BOWEL TRANSPLANTATION IN THE RATTransplantation, 1991
- Reimplantation response in isografted rat lungsThe Journal of Thoracic and Cardiovascular Surgery, 1984
- Lung Transplantation in the Rat: I. Technique and SurvivalThe Annals of Thoracic Surgery, 1982